- Home
- CWEN vs MMSI Comparison
CWEN vs MMSI Comparison
Compare CWEN & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CWEN | MMSI |
|---|---|---|
| Founded | 2012 | 1987 |
| Country | United States | United States |
| Employees | 60 | N/A |
| Industry | Electric Utilities: Central | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.1B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | CWEN | MMSI |
|---|---|---|
| Price | $32.74 | $71.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 8 |
| Target Price | $42.00 | ★ $98.88 |
| AVG Volume (30 Days) | ★ 1.5M | 802.8K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | ★ 4.71% | N/A |
| EPS Growth | N/A | ★ 4.93 |
| EPS | N/A | ★ 0.68 |
| Revenue | N/A | ★ $1,515,906,000.00 |
| Revenue This Year | $16.38 | $8.85 |
| Revenue Next Year | $8.48 | $5.88 |
| P/E Ratio | ★ $17.06 | $102.15 |
| Revenue Growth | N/A | ★ 11.75 |
| 52 Week Low | $27.67 | $59.74 |
| 52 Week High | $41.74 | $96.74 |
Technical Indicators
Market Signals| Indicator | CWEN | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 25.24 | 62.10 |
| Support Level | $31.87 | $66.19 |
| Resistance Level | $33.09 | $71.68 |
| Average True Range (ATR) | 1.28 | 2.12 |
| MACD | -0.48 | 0.30 |
| Stochastic Oscillator | 2.19 | 76.07 |
Price Performance
Historical ComparisonAbout CWEN Clearway Energy Inc. Class C
Clearway Energy Inc is a publicly-traded energy infrastructure investor with a focus on investments in clean energy and the owner of modern, sustainable, and long-term contracted assets across North America. The company segments its operations into Flexible Generation, Renewables & Storage, and Corporate divisions. The majority of its revenue is generated from the Renewables & Storage segment.
About MMSI Merit Medical Systems Inc.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.